Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-16 9:29 pm Purchase |
2025-01-09 | 13D | Quanterix Corporation QTRX |
Akoya Biosciences Inc. AKYA |
2,955,532 6.200% |
2,955,532 (New Position) |
Filing History |
| 2025-01-16 6:00 pm Purchase |
2025-01-09 | 13D | Akoya Biosciences, Inc. AKYA |
Quanterix Corp QTRX |
27,714,011 55.900% |
27,714,011 (New Position) |
Filing History |
| 2024-11-04 07:39 am Purchase |
2024-09-30 | 13G | Akoya Biosciences, Inc. AKYA |
Schindel Yair Chaim | 4,878,459 9.860% |
1,801,264 (+58.54%) |
Filing History |
| 2024-08-28 10:45 am Purchase |
2023-12-31 | 13G | Akoya Biosciences, Inc. AKYA |
Blue Water Life Science Advisors LP | 4,697,785 9.560% |
4,697,785 (New Position) |
Filing History |
| 2024-02-14 4:09 pm Purchase |
2023-12-31 | 13G | Akoya Biosciences, Inc. AKYA |
Telegraph Hill Partners III L.P. | 17,675,247 36.000% |
2,000,000 (+12.76%) |
Filing History |
| 2024-02-12 09:11 am Purchase |
2023-12-31 | 13G | Akoya Biosciences, Inc. AKYA |
PSC Capital Partners LLC | 3,517,360 7.200% |
800,000 (+29.44%) |
Filing History |
| 2024-01-03 08:50 am Purchase |
2023-12-31 | 13G | Akoya Biosciences, Inc. AKYA |
Schindel Yair Chaim | 3,077,195 6.270% |
158,756 (+5.44%) |
Filing History |
| 2023-06-13 07:18 am Purchase |
2023-06-12 | 13G | Akoya Biosciences, Inc. AKYA |
Schindel Yair Chaim | 2,918,439 6.030% |
2,918,439 (New Position) |
Filing History |
| 2023-02-15 09:15 am Unchanged |
2022-12-31 | 13G | Akoya Biosciences, Inc. AKYA |
PSC Capital Partners LLC | 2,717,360 7.200% |
0 (Unchanged) |
Filing History |
| 2023-02-14 3:47 pm Sale |
2022-12-31 | 13G | Akoya Biosciences, Inc. AKYA |
PSC Capital Partners LLC | 2,717,360 7.200% |
-96,411 (-3.43%) |
Filing History |
| 2023-02-07 4:30 pm Sale |
2023-02-03 | 13D | Akoya Biosciences, Inc. AKYA |
Hudson Executive Capital LP | 1,892,204 4.990% |
-555,354 (-22.69%) |
Filing History |
| 2022-12-02 4:15 pm Sale |
2022-11-30 | 13D | Akoya Biosciences, Inc. AKYA |
Hudson Executive Capital LP | 2,447,558 6.400% |
-1,250,000 (-33.81%) |
Filing History |
| 2022-09-13 4:10 pm Purchase |
2022-09-09 | 13D | Akoya Biosciences, Inc. AKYA |
Hudson Executive Capital LP | 3,697,558 9.800% |
1,617,015 (+77.72%) |
Filing History |
| 2022-02-25 10:57 am Purchase |
2021-12-31 | 13G | Akoya Biosciences, Inc. AKYA |
PSC Capital Partners LLC | 2,813,771 7.600% |
2,813,771 (New Position) |
Filing History |
| 2022-02-14 4:44 pm Unchanged |
2021-12-31 | 13G | Akoya Biosciences, Inc. AKYA |
Telegraph Hill Partners III L.P. | 15,675,247 42.100% |
0 (Unchanged) |
Filing History |
| 2021-10-18 4:02 pm Purchase |
2021-10-06 | 13D | Akoya Biosciences, Inc. AKYA |
Hudson Executive Capital LP | 2,080,543 5.600% |
2,080,543 (New Position) |
Filing History |
| 2021-05-28 4:01 pm Purchase |
2021-04-20 | 13G | Akoya Biosciences, Inc. AKYA |
Telegraph Hill Partners III L.P. | 15,675,247 42.700% |
15,675,247 (New Position) |
Filing History |